PIK3CA mutations in advanced ovarian carcinomas
✍ Scribed by Yun Wang; Åslaug Helland; Ruth Holm; Gunnar B. Kristensen; Anne-Lise Børresen-Dale
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 151 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
✦ Synopsis
PIK3CA belongs to the phosphatidylinositol 3-kinases (PI3Ks) family, which play an important role in proliferation, adherence, transformation and cell survival through the PI3K/AKT signaling pathway. Somatic activating mutations of this gene have recently been detected in several types of cancers. In the present study, 109 advanced ovarian carcinomas were analyzed for PIK3CA mutations in exon 9 and exon 20 by direct sequencing. Activating missense mutations were observed in 4 of the 109 tumors in addition to one variant leading no change of the PIK3CA protein. Two of the cases with mutations were mucinous and clear cell tumors, suggesting that PIK3CA mutations are more common in these rare histological types.
📜 SIMILAR VOLUMES
## Abstract Somatic mutations of the __PIK3CA__ gene, which encodes the p110α catalytic subunit of phosphatidylinositol 3‐kinase (PI3K), are frequent in various cancer types. The majority of mutations cluster at hotspots within exons 9 and 20, which encode the helical and kinase domains of p110α. _
## Abstract Somatic mutations of the __PIK3CA__ gene have recently been detected in various human cancers, including sporadic colorectal cancer. However, mutations of the __PIK3CA__ gene in hereditary colorectal cancers have not been clarified. To elucidate the mutation status in familial adenomato
## Abstract Mutation of __PIK3CA__, the gene coding for the p110α catalytic subunit of phosphoinositide 3‐kinase (PI3K), has been reported in a limited range of human tumors. We now report that __PIK3CA__ is also mutated in esophageal tumors. Single‐strand conformational polymorphism (SSCP) and den
Communicated by Richard
## Abstract While the phosphatidylinositol 3‐kinase (PI3K)/AKT signaling pathway is known to be activated in multiple sporadic cancers, the role of this pathway in familial tumors is mostly unknown. We searched for alterations in the catalytic domain of PI3K (__PIK3CA__), PTEN and __KRAS__, all of